| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | 0.0062 | 0.9 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.0073 | 0.9 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.9 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.0067 | 0.9 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.005 | 0.9 |